Shpall EJ - Search Results

1

The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer.

Jones RB, Shpall EJ, Shogan J, Affronti ML, Coniglio D, Hart L, Halperin E, Iglehart JD, Moore J, Gockerman J, et al. Jones RB, et al. Among authors: shpall ej. Cancer. 1990 Aug 1;66(3):431-6. doi: 10.1002/1097-0142(19900801)66:3<431::aid-cncr2820660305>3.0.co;2-x. Cancer. 1990. PMID: 2364358

2

Treatment of breast cancer in the 1990s. What does the future hold?

Jones RB, Shpall EJ. Jones RB, et al. Among authors: shpall ej. Drugs. 1992 Feb;43(2):141-5. doi: 10.2165/00003495-199243020-00001. Drugs. 1992. PMID: 1372213 Review. No abstract available.

3

Myocardial ischemia associated with high-dose carmustine infusion.

Kanj SS, Sharara AI, Shpall EJ, Jones RB, Peters WP. Kanj SS, et al. Among authors: shpall ej. Cancer. 1991 Nov 1;68(9):1910-2. doi: 10.1002/1097-0142(19911101)68:9<1910::aid-cncr2820680911>3.0.co;2-e. Cancer. 1991. PMID: 1655228

4

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.

Shpall EJ, Jones RB, Bast RC Jr, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggleston S, Tepperburg M, et al. Shpall EJ, et al. J Clin Oncol. 1991 Jan;9(1):85-93. doi: 10.1200/JCO.1991.9.1.85. J Clin Oncol. 1991. PMID: 1985173 Clinical Trial.

5

High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.

Jones RB, Shpall EJ, Ross M, Coniglio D, Affronti ML, Peters WP. Jones RB, et al. Among authors: shpall ej. Cancer Chemother Pharmacol. 1990;26(2):155-6. doi: 10.1007/BF02897264. Cancer Chemother Pharmacol. 1990. PMID: 2189592

6

High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study.

Peters WP, Stuart A, Klotman M, Gilbert C, Jones RB, Shpall EJ, Gockerman J, Bast RC Jr, Moore JO. Peters WP, et al. Among authors: shpall ej. Cancer Chemother Pharmacol. 1989;23(6):377-83. doi: 10.1007/BF00435840. Cancer Chemother Pharmacol. 1989. PMID: 2653660

7

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. Peters WP, et al. Among authors: shpall ej. J Clin Oncol. 1988 Sep;6(9):1368-76. doi: 10.1200/JCO.1988.6.9.1368. J Clin Oncol. 1988. PMID: 3047332

8

Intensive single-agent mitoxantrone for metastatic breast cancer.

Shpall EJ, Jones RB, Holland JF, Bhardwaj S, Paciucci PA, Wilfinger CL, Strashun A. Shpall EJ, et al. J Natl Cancer Inst. 1988 Apr 6;80(3):204-8. doi: 10.1093/jnci/80.3.204. J Natl Cancer Inst. 1988. PMID: 3279218 Clinical Trial.

9

New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.

Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB. Shpall EJ, et al. Breast Cancer Res Treat. 1993;26 Suppl:S19-23. doi: 10.1007/BF00668356. Breast Cancer Res Treat. 1993. PMID: 7691269 Clinical Trial.

10

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer.

Jones RB, Matthes S, Dufton C, Bearman SI, Stemmer SM, Meyers S, Shpall EJ. Jones RB, et al. Among authors: shpall ej. Breast Cancer Res Treat. 1993;26 Suppl:S11-7. doi: 10.1007/BF00668355. Breast Cancer Res Treat. 1993. PMID: 8400329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters